Target intelligence / Profile preview

Human papillomavirus type 16 and 18 E6 and E7 oncogenes (HPV16/18 E6/E7 DNA)

Target
HPV16/18 E6/E7 DNA
Molecular classification
Viral DNA, Oncogene
01

Overview

Human papillomavirus type 16 and 18 (HPV16/18) E6 and E7 oncogene DNA represents the genetic material of high-risk HPV strains responsible for the majority of cervical and other anogenital cancers (1, 4). These genes are typically integrated into the host cell genome during persistent infection, where they drive the oncogenic process by encoding the E6 and E7 oncoproteins (3, 11). E6 promotes the ubiquitination and degradation of the tumor suppressor protein p53, while E7 binds to and inactivates the retinoblastoma protein (pRb), leading to the loss of cell cycle control and the prevention of apoptosis (1, 4, 19). As a therapeutic target, the DNA sequences of these oncogenes are utilized in DNA vaccines like VGX-3100 and MEDI0457 to elicit a robust, antigen-specific CD8+ T-cell response against tumor cells (1, 5, 17). Additionally, modern gene-editing technologies such as CRISPR/Cas9 and TALENs are being developed to directly target and disrupt these DNA sequences within the host genome to halt oncoprotein production and induce tumor cell death (1, 6). Targeting the DNA level is a critical strategy for treating established HPV-associated malignancies and precancerous lesions where the virus has already integrated (2, 9). Clinical development of DNA-based therapies often involves electroporation or the use of adjuvants to enhance the relatively weak immunogenicity of plasmid DNA (5, 17). Overall, these oncogenes are the primary drivers of HPV-mediated transformation and remain the most promising targets for therapeutic intervention in HPV-related diseases (1, 11).

Other names
HPV16/18 E6/E7 DNAHigh-risk HPV E6 and E7 genesHPV16 E6/E7 and HPV18 E6/E7 DNAHPV16/18 E6 and E7 oncogene DNA
02

Mechanism of action

DNA vaccines deliver plasmid DNA encoding E6 and E7 to induce a T-cell mediated immune response against infected cells (1, 2, 5); gene-editing tools like CRISPR/Cas9 directly disrupt the viral DNA sequences to halt oncoprotein production and restore tumor suppressor functions (1, 6).

03

Biological functions

Viral replicationCell transformationApoptosis inhibitionCell cycle regulationProtein degradation
04

Disease associations

Cervical cancerHead and neck squamous cell carcinomaAnal cancerVulvar intraepithelial neoplasiaVaginal cancerPenile cancer
05

Safety considerations

Off-target effects of gene editingPotential for genomic integrationInjection site reactionsWeak immunogenicity requiring electroporation
06

Interacting drugs

VGX-3100

3 more in the full profile.

07

Biomarkers

HPV16/18 DNAE6/E7 mRNAp16INK4aIFN-gamma

Beyond the preview

Go deeper on Human papillomavirus type 16 and 18 E6 and E7 oncogenes (HPV16/18 E6/E7 DNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human papillomavirus type 16 and 18 E6 and E7 oncogenes (HPV16/18 E6/E7 DNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call